Vaxcyte
Price & Volume
Stats
See more52W Range | $58.10-$121.05 |
Market Cap | $9.9B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$75M |
Diluted EPS | -$4.60 |
News
See moreYahoo Finance • 11 days ago
Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
Yahoo Finance • 18 days ago
Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
Yahoo Finance • 24 days ago
Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference
Yahoo Finance • 24 days ago
Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm
About
CEO | Mr. Grant E. Pickering M.B.A. |
CFO | Mr. Andrew L. Guggenhime M.B.A. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 254 |
